Based on the transcript, here's a concise analysis and prediction for the short-term (1â€“2 weeks) impact on Procter & Gamble's stock:

### Analysis:
- **Performance vs. Expectations**: The company reported strong Q1 results, with organic sales growth at the high end of expectations and ahead of plan on operating profit, earnings per share, and cash. This indicates a positive performance relative to expectations.
- **Management's Tone**: Management maintained a balanced tone, emphasizing both growth and cost-cutting measures. They highlighted strategic initiatives in developing markets, innovation, and productivity improvements.
- **Guidance Updates**: The company provided updated guidance for 2013, expecting organic sales growth in the range of 2% to 4%, and core earnings per share in the range of $3.80 to $4.02. This guidance is slightly lower than previous expectations but still within a reasonable range.
- **External/Macro Influences**: The company did not significantly address external macroeconomic factors, focusing instead on internal strategic initiatives and market conditions.

### Conclusion:
Given the strong Q1 results and balanced guidance, the stock is likely to see a positive impact in the short term. The company's focus on innovation, productivity, and strategic growth in developing markets suggests a long-term growth trajectory, which could reassure investors. The slight reduction in guidance is expected to be manageable, and the company's strong balance sheet and track record of capital returns should continue to support the stock.

### Rating:
1